# Vera Bradley, Inc.: financial statements, quarterly

VRA · Nasdaq · CIK 1495320 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 30

Pages: [Overview](/companies/vra.md) · [Financials](/companies/vra/financials.md) · [Filings](/companies/vra/filings.md) · [Insiders](/companies/vra/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vra/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-10-28) | Q4 FY2024 (2024-02-03) | Q1 FY2025 (2024-05-04) | Q2 FY2025 (2024-08-03) | Q3 FY2025 (2024-11-02) | Q4 FY2025 (2025-02-01) | Q1 FY2026 (2025-05-03) | Q2 FY2026 (2025-08-02) | Q3 FY2026 (2025-11-01) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-05-02) | Q2 FY2027 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [115](/filings/0001495320-24-000091.md) | [46.2 d](/filings/0001628280-26-021640.md) | [67.9](/filings/0001628280-26-021640.md) | [94.0](/filings/0001628280-26-021640.md) | [70.5](/filings/0001628280-26-021640.md) | [86.4](/filings/0001628280-26-021640.md) | [51.7](/filings/0001628280-26-042444.md) | [70.9](/filings/0001628280-26-062019.md) | [62.3](/filings/0001628280-26-021640.md) | [84.9](/filings/0001628280-26-021640.md) | [55.7](/filings/0001628280-26-042444.md) | [71.6](/filings/0001628280-26-062019.md) |
| Cost of revenue | $m | [52.0](/filings/0001495320-24-000091.md) | [29.0 d](/filings/0001628280-26-021640.md) | [33.9](/filings/0001495320-25-000051.md) | [47.3](/filings/0001495320-25-000073.md) | [32.1](/filings/0001628280-25-056518.md) | [46.7 d](/filings/0001628280-26-021640.md) | [28.9](/filings/0001628280-26-042444.md) | [35.4](/filings/0001628280-26-062019.md) | [36.1](/filings/0001628280-25-056518.md) | [44.3 d](/filings/0001628280-26-021640.md) | [26.9](/filings/0001628280-26-042444.md) | [28.8](/filings/0001628280-26-062019.md) |
| Gross profit | $m | [63.0](/filings/0001495320-24-000091.md) | [17.2 d](/filings/0001628280-26-021640.md) | [34.0](/filings/0001628280-26-021640.md) | [46.7](/filings/0001628280-26-021640.md) | [38.4](/filings/0001628280-26-021640.md) | [39.7](/filings/0001628280-26-021640.md) | [22.8](/filings/0001628280-26-042444.md) | [35.5](/filings/0001628280-26-062019.md) | [26.2](/filings/0001628280-26-021640.md) | [40.6](/filings/0001628280-26-021640.md) | [28.8](/filings/0001628280-26-042444.md) | [42.8](/filings/0001628280-26-062019.md) |
| Selling, general and administrative | $m | [56.4](/filings/0001495320-24-000091.md) | [19.0 d](/filings/0001628280-26-021640.md) | [45.1](/filings/0001495320-25-000051.md) | [44.4](/filings/0001495320-25-000073.md) | [46.7](/filings/0001628280-25-056518.md) | [52.2 d](/filings/0001628280-26-021640.md) | [40.8](/filings/0001628280-26-042444.md) | [40.4](/filings/0001628280-26-062019.md) | [38.7](/filings/0001628280-25-056518.md) | [38.2 d](/filings/0001628280-26-021640.md) | [34.1](/filings/0001628280-26-042444.md) | [38.7](/filings/0001628280-26-062019.md) |
| Operating income | $m | [6.8](/filings/0001495320-24-000091.md) | [(1.7) d](/filings/0001628280-26-021640.md) | [(10.6)](/filings/0001495320-25-000051.md) | [2.4](/filings/0001495320-25-000073.md) | [(8.2)](/filings/0001628280-25-056518.md) | [(12.4) d](/filings/0001628280-26-021640.md) | [(17.9)](/filings/0001628280-26-042444.md) | [(4.6)](/filings/0001628280-26-062019.md) | [(12.2)](/filings/0001628280-25-056518.md) | [2.7 d](/filings/0001628280-26-021640.md) | [(4.6)](/filings/0001628280-26-042444.md) | [4.2](/filings/0001628280-26-062019.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.0](/filings/0001495320-24-000091.md) | [(0.1) d](/filings/0001628280-26-021640.md) | [(2.5)](/filings/0001495320-25-000051.md) | [(4.9)](/filings/0001495320-25-000073.md) | [5.2](/filings/0001628280-25-056518.md) | [7.6 d](/filings/0001628280-26-021640.md) | [0.4](/filings/0001628280-26-042444.md) | [(0.0)](/filings/0001628280-26-062019.md) | [0.1](/filings/0001628280-25-056518.md) | [(0.1) d](/filings/0001628280-26-021640.md) | [0.1](/filings/0001628280-26-042444.md) | [(0.1)](/filings/0001628280-26-062019.md) |
| Net income | $m | [5.1](/filings/0001495320-24-000091.md) | [(1.9) d](/filings/0001628280-26-021640.md) | [(8.1)](/filings/0001628280-26-021640.md) | [5.7](/filings/0001628280-26-021640.md) | [(12.8)](/filings/0001628280-26-021640.md) | [(47.0)](/filings/0001628280-26-021640.md) | [(33.5)](/filings/0001628280-26-062019.md) | [(4.7)](/filings/0001628280-26-062019.md) | [(12.4)](/filings/0001628280-26-021640.md) | [2.7](/filings/0001628280-26-021640.md) | [(4.8)](/filings/0001628280-26-062019.md) | [4.5](/filings/0001628280-26-062019.md) |
| Diluted EPS | $ per share | [0.16](/filings/0001495320-24-000091.md) | not reported | [(0.26)](/filings/0001628280-26-021640.md) | [0.19](/filings/0001628280-26-021640.md) | [(0.46)](/filings/0001628280-26-021640.md) | [(1.69)](/filings/0001628280-26-021640.md) | [(1.20)](/filings/0001628280-26-042444.md) | [(0.17)](/filings/0001628280-26-062019.md) | [(0.44)](/filings/0001628280-26-021640.md) | [0.09](/filings/0001628280-26-021640.md) | [(0.17)](/filings/0001628280-26-042444.md) | [0.15](/filings/0001628280-26-062019.md) |
| Basic EPS | $ per share | [0.17](/filings/0001495320-24-000091.md) | not reported | [(0.26)](/filings/0001628280-26-021640.md) | [0.19](/filings/0001628280-26-021640.md) | [(0.46)](/filings/0001628280-26-021640.md) | [(1.69)](/filings/0001628280-26-021640.md) | [(1.20)](/filings/0001628280-26-042444.md) | [(0.17)](/filings/0001628280-26-062019.md) | [(0.44)](/filings/0001628280-26-021640.md) | [0.10](/filings/0001628280-26-021640.md) | [(0.17)](/filings/0001628280-26-042444.md) | [0.16](/filings/0001628280-26-062019.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-10-28) | FY2024 (2024-02-03) | Q1 FY2025 (2024-05-04) | Q2 FY2025 (2024-08-03) | Q3 FY2025 (2024-11-02) | FY2025 (2025-02-01) | Q1 FY2026 (2025-05-03) | Q2 FY2026 (2025-08-02) | Q3 FY2026 (2025-11-01) | FY2026 (2026-01-31) | Q1 FY2027 (2026-05-02) | Q2 FY2027 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [52.3](/filings/0001495320-23-000063.md) | [77.3](/filings/0001495320-25-000019.md) | [55.2](/filings/0001495320-24-000050.md) | [44.1](/filings/0001495320-24-000065.md) | [13.7](/filings/0001495320-24-000091.md) | [28.6](/filings/0001628280-26-021640.md) | [11.3](/filings/0001495320-25-000051.md) | [15.2](/filings/0001495320-25-000073.md) | [10.7](/filings/0001628280-25-056518.md) | [18.5](/filings/0001628280-26-062019.md) | [12.5](/filings/0001628280-26-042444.md) | [34.2](/filings/0001628280-26-062019.md) |
| Current assets | $m | [221](/filings/0001495320-23-000063.md) | [226](/filings/0001495320-25-000019.md) | [218](/filings/0001495320-24-000050.md) | [223](/filings/0001495320-24-000065.md) | [185](/filings/0001495320-24-000091.md) | [165](/filings/0001628280-26-021640.md) | [136](/filings/0001495320-25-000051.md) | [140](/filings/0001495320-25-000073.md) | [122](/filings/0001628280-25-056518.md) | [120](/filings/0001628280-26-062019.md) | [111](/filings/0001628280-26-042444.md) | [126](/filings/0001628280-26-062019.md) |
| Total assets | $m | [383](/filings/0001495320-23-000063.md) | [381](/filings/0001495320-25-000019.md) | [369](/filings/0001495320-24-000050.md) | [379](/filings/0001495320-24-000065.md) | [359](/filings/0001495320-24-000091.md) | [307](/filings/0001628280-26-021640.md) | [268](/filings/0001495320-25-000051.md) | [266](/filings/0001495320-25-000073.md) | [244](/filings/0001628280-25-056518.md) | [234](/filings/0001628280-26-062019.md) | [219](/filings/0001628280-26-042444.md) | [239](/filings/0001628280-26-062019.md) |
| Current liabilities | $m | [57.0](/filings/0001495320-23-000063.md) | [58.3](/filings/0001495320-25-000019.md) | [63.0](/filings/0001495320-24-000050.md) | [78.3](/filings/0001495320-24-000065.md) | [59.8](/filings/0001495320-24-000091.md) | [58.0](/filings/0001628280-26-021640.md) | [59.5](/filings/0001495320-25-000051.md) | [57.7](/filings/0001495320-25-000073.md) | [48.6](/filings/0001628280-25-056518.md) | [50.5](/filings/0001628280-26-062019.md) | [45.0](/filings/0001628280-26-042444.md) | [51.6](/filings/0001628280-26-062019.md) |
| Total liabilities | $m | [121](/filings/0001495320-23-000063.md) | [121](/filings/0001495320-25-000019.md) | [123](/filings/0001495320-24-000050.md) | [137](/filings/0001495320-24-000065.md) | [134](/filings/0001495320-24-000091.md) | [128](/filings/0001628280-26-021640.md) | [122](/filings/0001495320-25-000051.md) | [126](/filings/0001495320-25-000073.md) | [116](/filings/0001628280-25-056518.md) | [102](/filings/0001628280-26-062019.md) | [92.2](/filings/0001628280-26-042444.md) | [107](/filings/0001628280-26-062019.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-25-056518.md) | not reported | [10.0](/filings/0001495320-25-000073.md) | [10.0](/filings/0001628280-25-056518.md) | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [262](/filings/0001495320-23-000063.md) | [260](/filings/0001495320-25-000019.md) | [246](/filings/0001495320-24-000050.md) | [243](/filings/0001495320-24-000065.md) | [225](/filings/0001495320-24-000091.md) | [179](/filings/0001628280-26-021640.md) | [146](/filings/0001495320-25-000051.md) | [140](/filings/0001495320-25-000073.md) | [128](/filings/0001628280-25-056518.md) | [132](/filings/0001628280-26-062019.md) | [127](/filings/0001628280-26-042444.md) | [132](/filings/0001628280-26-062019.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-10-28) | Q4 FY2024 (2024-02-03) | Q1 FY2025 (2024-05-04) | Q2 FY2025 (2024-08-03) | Q3 FY2025 (2024-11-02) | Q4 FY2025 (2025-02-01) | Q1 FY2026 (2025-05-03) | Q2 FY2026 (2025-08-02) | Q3 FY2026 (2025-11-01) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-05-02) | Q2 FY2027 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [5.1 d](/filings/0001495320-24-000091.md) | [26.9 d](/filings/0001628280-26-021640.md) | [(14.5)](/filings/0001495320-25-000051.md) | [1.4 d](/filings/0001495320-25-000073.md) | [(22.6) d](/filings/0001628280-25-056518.md) | [21.7 d](/filings/0001628280-26-021640.md) | [(17.9)](/filings/0001628280-26-042444.md) | [(5.4) d](/filings/0001628280-26-062019.md) | [(4.0) d](/filings/0001628280-25-056518.md) | [17.3 d](/filings/0001628280-26-021640.md) | [(5.3)](/filings/0001628280-26-042444.md) | [23.0 d](/filings/0001628280-26-062019.md) |
| Capital expenditure | $m | [0.8 d](/filings/0001495320-24-000091.md) | [1.2 d](/filings/0001628280-26-021640.md) | [0.9](/filings/0001495320-25-000051.md) | [2.8 d](/filings/0001495320-25-000073.md) | [2.4 d](/filings/0001628280-25-056518.md) | [4.3 d](/filings/0001628280-26-021640.md) | [1.9](/filings/0001628280-26-042444.md) | [0.7 d](/filings/0001628280-26-062019.md) | [0.5 d](/filings/0001628280-25-056518.md) | [0.2 d](/filings/0001628280-26-021640.md) | [0.3](/filings/0001628280-26-042444.md) | [0.7 d](/filings/0001628280-26-062019.md) |
| Share repurchases | $m | [0.5 d](/filings/0001495320-24-000091.md) | [0.3 d](/filings/0001628280-26-021640.md) | [6.3](/filings/0001495320-25-000051.md) | [9.5 d](/filings/0001495320-25-000073.md) | [5.3 d](/filings/0001628280-25-056518.md) | [0.6 d](/filings/0001628280-26-021640.md) | [0.0](/filings/0001495320-25-000051.md) | [0.0 d](/filings/0001495320-25-000073.md) | [0.0 d](/filings/0001628280-25-056518.md) | [0.0 d](/filings/0001628280-26-021640.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-10-29) | Q1 FY2024 (2023-04-29) | Q2 FY2024 (2023-07-29) | Q3 FY2024 (2023-10-28) | Q1 FY2025 (2024-05-04) | Q2 FY2025 (2024-08-03) | Q3 FY2025 (2024-11-02) | Q1 FY2026 (2025-05-03) | Q2 FY2026 (2025-08-02) | Q3 FY2026 (2025-11-01) | Q1 FY2027 (2026-05-02) | Q2 FY2027 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [31.2](/filings/0001495320-23-000063.md) | [30.8](/filings/0001495320-24-000050.md) | [31.1](/filings/0001495320-24-000065.md) | [31.3](/filings/0001495320-24-000091.md) | [30.7](/filings/0001495320-25-000051.md) | [29.8](/filings/0001495320-25-000073.md) | [28.1](/filings/0001628280-25-056518.md) | [27.8](/filings/0001628280-26-042444.md) | [27.9](/filings/0001628280-26-062019.md) | [27.9](/filings/0001628280-25-056518.md) | [28.1](/filings/0001628280-26-042444.md) | [30.0](/filings/0001628280-26-062019.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 28,688,664 at 2026-09-08, from the cover of the [10-Q filed 2026-09-15](/filings/0001628280-26-062019.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.